CD34 and myelodysplastic syndrome: Conversely, HMA may inhibit T-cell proliferation and pro-inflammatory cytokine secretion with simultaneous induction of regulatory T cells (Tregs) (34, 35), while the HMA-induced increase in the expression of immune checkpoint molecules in clonal CD34+ progenitors is associated with refractory disease in patients with high-risk MDS (36).